Cardiomyopathy Clinical Trials in Bologna
3 recruitingBologna, Italy
Showing 1–3 of 3 trials
Recruiting
Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S1,280 enrolled285 locationsNCT07207811
Recruiting
Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company582 enrolled94 locationsNCT06563895
Recruiting
Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis
Cardiomyopathy
IRCCS Azienda Ospedaliero-Universitaria di Bologna750 enrolled1 locationNCT06866912